MedTrace Logo

Effect of Probiotic on Constipation in Patients With Parkinson's Disease

NCT04293159 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-05-20

No results posted yet for this study

Summary

The aim of the study is to collect data for the assessment of the Lactobacillus casei DG (Enterolactis ®duo) effect on constipation and on neuropsychological performance

Conditions

Interventions

DIETARY_SUPPLEMENT

Lactobacillus casei DG (Enterolactis duo®)

Lactobacillus casei DG (Enterolactis duo®)

Sponsors & Collaborators

  • Roberto Erro

    collaborator UNKNOWN

  • Maria Teresa Pellecchia

    collaborator UNKNOWN

  • Antonella Santonicola

    collaborator UNKNOWN

  • Carolina Ciacci

    collaborator UNKNOWN

  • University of Salerno

    lead OTHER

Principal Investigators

  • PAOLA IOVINO, MD · University of Salerno

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-14
Primary Completion
2022-12-31
Completion
2023-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04293159 on ClinicalTrials.gov